Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Dimension Therapeutics, Inc. ("Dimension Therapeutics" or the "Company") (NASDAQ: DMTX) relating to the sale of the Company to affiliates of REGENXBIO Inc. (RGNX). As a result of the merger, Dimension Therapeutics shareholders are only anticipated to receive 0.1573 shares of REGENXBIO in exchange for each share of Dimension Therapeutics.

Click here for more information: http://monteverdelaw.com/investigations/m-a/. It is free and there is no cost or obligation to you.

The investigation focuses on whether the tender offer is a fair price and all material financial information is adequately disclosed in connection with the tender offer set to expire on November 6, 2017.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

If you own common stock in Dimension Therapeutics and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 477701

"/> SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Of Dimension Therapeutics, Inc. – DMTX « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
MarketersMEDIA Year End Sale is Finally Back! Get up to 70% OFF on your press releases. Hurry! Limited time only.
Click Here
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Of Dimension Therapeutics, Inc. – DMTX

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Of Dimension Therapeutics, Inc. – DMTX

Share This Press Release

NEW YORK, NY / ACCESSWIRE / October 12, 2017 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Dimension Therapeutics, Inc. ("Dimension Therapeutics" or the "Company") (NASDAQ: DMTX) relating to the sale of the Company to affiliates of REGENXBIO Inc. (RGNX). As a result of the merger, Dimension Therapeutics shareholders are only anticipated to receive 0.1573 shares of REGENXBIO in exchange for each share of Dimension Therapeutics.

Click here for more information: http://monteverdelaw.com/investigations/m-a/. It is free and there is no cost or obligation to you.

The investigation focuses on whether the tender offer is a fair price and all material financial information is adequately disclosed in connection with the tender offer set to expire on November 6, 2017.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

If you own common stock in Dimension Therapeutics and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 477701

NEW YORK, NY / ACCESSWIRE / October 12, 2017 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Dimension Therapeutics, Inc. ("Dimension Therapeutics" or the "Company") (NASDAQ: DMTX) relating to the sale of the Company to affiliates of REGENXBIO Inc. (RGNX). As a result of the merger, Dimension Therapeutics shareholders are only anticipated to receive 0.1573 shares of REGENXBIO in exchange for each share of Dimension Therapeutics.

Click here for more information: http://monteverdelaw.com/investigations/m-a/. It is free and there is no cost or obligation to you.

The investigation focuses on whether the tender offer is a fair price and all material financial information is adequately disclosed in connection with the tender offer set to expire on November 6, 2017.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

If you own common stock in Dimension Therapeutics and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 477701

Source URL: https://marketersmedia.com/shareholder-alert-monteverde-associates-pc-announces-an-investigation-of-dimension-therapeutics-inc-dmtx/249765

Source: AccessWire

Release ID: 249765

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2017 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).